Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection [Phase 3]
Phase 3 trial evaluating safety and efficacy of a single-dose combination of Dactavira in Egyptian adults with chronic genotype 4 hepatitis …
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011) [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of grazoprevir and uprifosbuvir with either elbasvir or ruzasvir in chronic Hepatitis C g…
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C [Phase 2]
A Phase 2a dose-ranging study assessing VX-135 with ribavirin in treatment-naïve chronic hepatitis C patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection [Phase 3]
Phase 3 trial evaluating Ledipasvir/Sofosbuvir with or without Ribavirin in Egyptian adults with chronic genotype 4 HCV; results posted afte…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa [Phase 2]
A Phase 2 trial in West and Central Africa evaluated interferon-free sofosbuvir plus ribavirin for genotype 2 and sofosbuvir/ledipasvir for …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy [Phase 3]
Phase 3 trial update evaluating safety and efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in adults with chronic hepatitis C who previously…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults [Phase 3]
Phase 3 trial of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in treatment-naïve adults with Hepatitis C Genotype 1b completed; results p…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma [Phase 3]
A Phase 3 study evaluating an all-oral regimen of ombitasvir/paritaprevir/ritonavir with or without dasabuvir and with or without ribavirin …
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects [Phase 2]
Phase 2 trial evaluating the antifibrotic agent GI262570 in patients with chronic hepatitis C and liver cirrhosis has completed, with result…
-
FDA approval · 2017-12-11FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for MAVYRET (glecaprevir and pibrentasvir) submitted by AbbVie, updating its regulatory status f…
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects [Phase 2]
Phase 2 study evaluating safety, antiviral activity, and pharmacokinetics of GSK2336805 in combination with peginterferon and ribavirin in c…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients [Phase 4]
Phase 4 trial evaluating generic Velpatasvir/sofosbuvir with or without ribavirin in HIV/HCV coinfected patients; the study status is comple…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection [Phase 2]
Phase 2 trial assessing safety and efficacy of voxilaprevir with sofosbuvir/velpatasvir fixed-dose combination for adults with chronic genot…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Pilot Study of HIV and Hepatitis B and C Screening in Surgery
This completed pilot trial evaluated screening for HIV, hepatitis B, and hepatitis C among surgical patients.
-
CLINICAL_TRIALS research · 2017-12-07Clinical Trial Update: The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia [NA]
A clinical trial is examining how direct-acting antiviral therapy for hepatitis C affects hepatitis C–related thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study [Phase 4]
A Phase 4 pilot trial update aimed at eliminating hepatitis C virus. The study involves participants with Hepatitis C and heroin addiction, …
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease [Phase 3]
A Phase 3 trial evaluating Ombitasvir/Paritaprevir/Ritonavir with or without Dasabuvir in adults with genotype 1a or 4 chronic hepatitis C a…
-
CLINICAL_TRIALS research · 2017-12-02Clinical Trial Update: Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant [Phase 4]
A Phase 4 clinical trial evaluating the fixed-dose combination grazoprevir/elbasvir for hepatitis C virus genotype 4 in kidney transplant re…
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection [Phase 2]
Phase 2 trial update of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Sofosbuvir and Ribavirin in treatment-experienced ad…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects [Phase 1]
A Phase 1 trial of ABT-333 was conducted in healthy volunteers and Hepatitis C genotype 1 infected subjects; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy
A completed trial evaluating Anti-E1E2 (D32.10 epitope-binding) antibodies suggests prior therapy favors the efficacy of direct-acting antiv…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Side Effects After Direct-acting Antiviral Treatment
This clinical trial update summarizes the side effects observed after direct-acting antiviral therapy for chronic hepatitis C. The informati…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1 [Phase 1]
A Phase 1 safety, tolerability, and pharmacokinetic study evaluating single doses of ABT-450 with and without ritonavir in adults with Hepat…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection [Phase 2]
Phase 2 trial evaluating safety and efficacy of ledipasvir/sofosbuvir fixed-dose combination for 12 or 24 weeks in kidney transplant recipie…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection [Phase 2, Phase 3]
A multi-part open-label study evaluated ABT-450/r/ABT-267 with or without ABT-333 and ribavirin in adults with genotype 1 or 4 HCV, with or …